Arrowhead Research | ARWR - Pre Utilidad Fiscal

Precio De Mercado
75.57
Cambio Diario
0.03 0.04%
Mensual
1.57%
Anual
399.47%
Q2 Expectativa
75.13




Pre Utilidad Fiscal Cambio Fecha
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Anika Therapeutics USD 764K 3M 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 343.6M 46.34M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
Ligand Pharmaceuticals USD 56.78M 84.36M 2025-12
Merck USD 3.42B 3.32B 2025-12
Moderna USD -799M 612M 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novartis USD 3.84B 802M 2026-03
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
TG Therapeutics USD 20.36M 24.73M 2026-03
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03
Xencor USD -128.64M 124.37M 2026-03